CYCLOMEDICA USA, LLC

CYCLOMEDICA USA, LLC specializes in the manufacturing of pharmaceutical preparations and the leasing of specialized medical gas delivery systems for federal healthcare and defense applications. Their core capabilities center on the production of radiopharmaceutical kits—particularly those for technetium-based diagnostic agents—and the provision of integrated TECHNEGAS system leases, including service agreements that ensure operational continuity in nuclear medicine environments. The company demonstrates technical expertise in radiopharmaceutical formulation, aseptic processing, and the maintenance of GMP-compliant manufacturing protocols for diagnostic imaging agents. Their unique specialization lies in bridging pharmaceutical manufacturing with medical equipment leasing, offering end-to-end solutions for nuclear medicine departments that require both sterile drug products and reliable gas delivery infrastructure. The contractor maintains a strong, consistent relationship with the Department of Veterans Affairs, delivering pharmaceuticals under Federal Supply Schedule 65I-B and supporting nuclear medicine operations through TECHNEGAS system leases and service agreements. They also serve the Department of Defense with mission-critical radiopharmaceutical kits, indicating alignment with military medical logistics and battlefield diagnostics requirements. Their work with the 257-NETWORK Contract Office suggests engagement in specialized procurement pathways for niche medical technologies. The primary NAICS classification of 325412 reflects active involvement in pharmaceutical preparation manufacturing, specifically for diagnostic radiopharmaceuticals, while 532490 indicates a parallel focus on leasing high-value medical gas systems used in nuclear imaging. This dual vertical positioning allows CYCLOMEDICA to serve as a single-source provider for nuclear medicine workflows. As a 2L entity based in Tucker, Georgia, CYCLOMEDICA USA, LLC operates as a small business without federal certifications. Their market positioning is defined by technical precision in radiopharmaceuticals and medical equipment support, targeting federal healthcare and defense agencies with specialized, mission-essential solutions.